Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Observational × Hyperaldosteronism × Clear all

Status

Recruiting 6 Completed 5 Unknown 3 Enrolling by invitation 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 129 Neoplasms 125 Lung Neoplasms 63 Prostatic Neoplasms 60 Carcinoma, Non-Small-Cell Lung 52 Colorectal Neoplasms 37 Multiple Myeloma 34 Pancreatic Neoplasms 28 Melanoma 28 Neoplasm Metastasis 27 Head and Neck Neoplasms 27 Brain Neoplasms 26 Ovarian Neoplasms 24 Liver Neoplasms 23 Leukemia, Myeloid, Acute 23 Carcinoma, Hepatocellular 22 Esophageal Neoplasms 19 Lymphoma 18 Leukemia, Lymphocytic, Chronic, B-Cell 18 Colonic Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Non-Hodgkin 17 Carcinoma, Renal Cell 17 Sarcoma 16 Glioma 16 Glioblastoma 16 Urinary Bladder Neoplasms 15 Lymphoma, Follicular 15 Stomach Neoplasms 14 Recurrence 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05456997 2023-10-16

LYDIA

Barts & The London NHS Trust

Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡